RX PRODUCTS
Since 1990, Stragen has always been committed to the development of Selected and Advanced Generics
As a result of decades of experience and expertise in R&D, combined with our continuous commitment to advancing public health, we constantly aim at improving the existing therapeutics by offering:
- Niche molecules
- Hard-to-make drugs
- Innovative delivery forms to improve health daily practices
Therapeutic Areas
Gesdonyl®20
Ethinylestradiol 20 µg / Gestodene 75 µg
Gynaecology
Ridne® 35
Ethinylestradiol 35 µg / Cyproterone acetate 2 mg
Gynaecology
No Results Found